| Price and Chart delayed at least 15 mintues. |
|
Price
$ 19.77
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
19.77
|
Volume
NA
|
|
Market Value
39 bil
|
P/E Ratio
7.6
|
|
Bid
18.06
|
EPS
2.62
|
|
Ask
22.11
|
Dividend
1.24
|
|
High
0.00
|
Yield
6.3
|
|
Low
0.00
|
Shares Out
1.98 bil
|
|
52wk High
23.98
|
52wk Low
16.00
|
|
Industry: Drug Manufacturers - Major
|
|
Sector: Healthcare
|
BMY Profile
A global biopharmaceutical company, which through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products.
Bristol-Myers Squibb Co.
345 Park Avenue
New York, NY 10154
Phone: (212) 546-4000
Fax: (212) 546-4020
Web Site: www.bms.com
BMY Wires Headlines
|
|
| 07.02.09 |
|
Final Glance: Pharmaceuticals companies
|
|
| 07.02.09 |
|
GlaxoSmithKline buys products from Bristol-Myers
|
|
| 07.02.09 |
|
Midday Glance: Pharmaceuticals companies
|
|
| 07.02.09 |
|
Early Glance: Pharmaceuticals companies
|
|
| 07.02.09 |
|
UPDATE 1-Glaxo buys Bristol generic drugs in Mideast
|
More BMY From Wires Headlines >
Forbes.com on BMY RSS
|
|
|
Bristol-Myers Squibb is ranked # 176 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on BMY
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on BMY
RSS News Feed on BMY
|
A D V E R T I S E M E N T
|